MSP-1 malaria pseudopeptide analogs: Biological and immunological significance and three-dimensional structure

Biological Chemistry

Volumn 384, Issue 1, 2003, Pages 71-82

  Lozano, José Manuel ^a   Alba, Martha Patricia ^a   Vanegas, Magnolia ^a   Silva, Yolanda ^a   Torres Castellanos, Josæ Libardo ^b   Patarroyo, Manuel Elkin ^a  

^a FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

^b NONE

Author keywords

Merozoite surface protein 1 (MSP 1); Pseudopeptide; Transition state analog

Indexed keywords

AMIDE; FREUND ADJUVANT; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MALARIA VACCINE; MEROZOITE SURFACE PROTEIN 1; PEPTIDE ANTIBODY; PSEUDOPEPTIDE;

ALLELE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANTIGEN BINDING; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; IMMUNOGENICITY; INFECTION PREVENTION; NONHUMAN; PARASITE VIRULENCE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN MODIFICATION; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; STRUCTURE ANALYSIS; VACCINE PRODUCTION;

ALDEHYDES; AMIDES; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; CHROMATOGRAPHY, THIN LAYER; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HLA-DR ANTIGENS; HUMANS; IMMUNOBLOTTING; MAGNETIC RESONANCE SPECTROSCOPY; MEROZOITE SURFACE PROTEIN 1; MICE; MICE, INBRED BALB C; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; PROTEIN BINDING; PROTEIN CONFORMATION; SOLVENTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

ANIMALIA; PLASMODIUM FALCIPARUM;

EID: 0037224773     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2003.008     Document Type: Review

References (29)

1. 33 as a non-covalently associated complex with other fragments of the MSP-1. Mol. Biochem. Parasitol. 50, 307-316.
2. Bax, A., and Davis, D. (1985). MLEV-17 based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65, 355-360.
3. Dalton, J.P., McNally, J., and O'Donovan, S.M. (1993). In vitro assays for study of erythrocyte invasion by malarial parasites. Parasitol. Today 9, 109-111.
4. Dessen, A., Lawrence, C.M., Cupo, S., Zaller, D.M., and Wiley, D.C. (1997). X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity 7, 473-481.
5. Espejo, F., Cubillos, M., Salazar, L. M., Guzmán, F., Urquiza, M., Ocampo, M., Silva, Y., Rodriguez, R., Lioy, E., and Patarroyo, M. E. (2001). Structure, immunogenicity, and protectivity relationship for the 1585 malarial peptide and its substitution analogues. Angew. Chem. Int. Ed. 40, 4654-4657.
6. Espinal, C., Cortés, G., Guerra, P., and Arias, A. (1985). Sensitivity of Plasmodium falciparum to antimalarial drugs in Colombia. Am. J. Trop. Med. Hyg. 34, 675-680.
7. Fehrentz, J.A., and Castro, B. (1983). An efficient synthesis of optically active α-(t-butoxycarbonylamino)-aldehydes from α-amino acids. Synthesis 676-678.
8. Ghosh, P., Amaya, M., Mellins, E., and Wiley, D.C. (1995). The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378, 457-462.
9. Graves, P., Gelband, H., and Garne, P. (1998). The SPf-66 malaria vaccine: what is the evidence for efficacy? Parasitol. Today 14, 219.
10. Guichard, G., Calbo, S., Muller, S., Kourilsky, P., and Abastado, J.P. (1995). Efficient binding of reduced peptide bond pseudopeptides to major histocompatibility complex class I molecule. J. Biol. Chem. 270, 26057-26064.
11. Holder, A., Lockyer, M.J., and Odink, K.G. (1985). Primary structure of the precursor to the three major antigens of Plasmodium falciparum merozoites. Nature 317, 270-273.
12. Houghten, R.A. (1985). General method for the rapid solid-phase peptide synthesis of the large number of peptides: specificity of antigen-antibody interactions of the level of individual amino acids. Proc. Natl. Acad. Sci. USA 82, 5131.
13. Jeener, J. Meier, B., Backman, P., and Ernst, R. (1979). Investigation of enhance processes by two dimensional NMR spectroscopy. J. Chem. Phys. 71, 4546-4553.
14. Jouin, H., Rogier, C., Trape, J-F., and Puijalon, M. (2001). Fixed, epitope-specific, cytophilic antibody response to the polymorphic block 2 domain of the Plasmodium falciparum merozoite surface antigen MSP-1 in humans living in a malaria-endemic area. Eur. J. Immunol. 31, 539-550.
15. Kabelitz, D., and Janssen, O. (1989). Growth inhibition of Epstein-Barr virus-transformed B cells by anti HLA-DR antibody L243: possible relationship to L243-induced down-regulation of CD23 antigen expression. Cell Immunol. 120, 211-230.
16. Lambros, C., and Vanderberg, J.P. (1979). Synchronization of Plasmodium falciparum erythrocite stages in culture. J. Parasitol. 65, 418-420.
17. Lozano, J.M., Espejo, F., Diaz, D., Salazar, L.M., Rodríguez, J., Pinzón, C., Calvo, J.C., Guzmán, F., and Patarroyo, M.E. (1998). Reduced amide pseudopeptide analogues of a malaria peptide possess secondary structural elements responsible for induction of functional antibodies which react with native proteins expressed in Plasmodium falciparum erythrocyte stages. J. Peptide Res. 52, 457-469.
18. Merrifield, R.B. (1963). Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem, Soc. 85, 2149.
19. Patarroyo, M.E., Romero, P., Torres, M.L., Clavijo, P., Moreno, A., Martínez, A., Rodríguez, R., Guzmán, F., Cabezas, E. (1987). Induction of protective immunity against experimental infection with malaria using synthetic peptides. Nature 328, 629-632.
20. Patarroyo, M.E., Amador, R., Clavijo, P., Moreno, A., Guzmán, F., Romero, P., Tascón R., Franco, A., Murillo, L., Pontón, G., Trujillo, G. (1988). A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria vaccine. Nature 332, 158-161.
21. Plugariu, C., Stockner, T., Sterk, H., and Haegenauer, G. (1998). Conformational behavior of the TraM headpiece. J. Peptide Res. 51, 244-250.
22. 1H-NMR spectra of proteins via double quantum filtering. Biochem. Biophys. Res. Commun. 117, 479-485.
23. 2NH] pseudopeptide analogues of a highly potent somatostatin octapeptide. J. Med. Chem. 30, 1162-1166.
24. Sloan-Lancaster, J., and Allen, P. (1995). Significance of T-cell stimulation by altered peptide ligands in T cell biology. Curr. Opin. Immunol. 7, 103-109.
25. Stern, L.J., Brown, J.H., Jardetzky, T.S., Gorga, J.C., Urban, R.G., Strominger, J.L., and Wiley, D.C. (1994). Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368, 215-221.
26. Tropical Disease Research: Progress Thirteenth Programme Report of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, Geneva, (1997), pp 40-61.
27. Urquiza, M., Rodriguez, L., Suarez, J., Guzmán, F., Ocampo, M., Curtidor, H., Segura, C., Trujillo, E., and Patarroyo, M.E. (1996). Identification Plasmodium falciparum MSP-1 peptides able to bind to human red blood cells. Parasite Immunol. 18, 505-526.
28. Walgers, R., Lee, T., and Cammers-Goodwin, A. (1998). An indirect chaotropic mechanism for the stabilization of helix conformation of peptides in aqueous trifluoroethanol and hexafluoro-2-propanol. J. Am. Chem. Soc. 12, 5073-5079.
29. Wüthrich, K. (1986). NMR of Proteins and Nucleic Acids, 2nd Edition (New York, USA: John Wiley & Sons), pp. 207-215.